| 73606-020-01 |
73606-020 |
HUMAN PRESCRIPTION DRUG |
Syfovre |
Pegcetacoplan |
INJECTION, SOLUTION |
INTRAVITREAL |
20230217 |
N/A |
NDA |
NDA217171 |
Apellis Pharmaceuticals, Inc. |
PEGCETACOPLAN |
15 mg/.1mL |
1 VIAL, GLASS in 1 CARTON (73606-020-01) / 3 mL in 1 VIAL, GLASS |
| 73606-020-02 |
73606-020 |
HUMAN PRESCRIPTION DRUG |
Syfovre |
Pegcetacoplan |
INJECTION, SOLUTION |
INTRAVITREAL |
20251107 |
N/A |
NDA |
NDA217171 |
Apellis Pharmaceuticals, Inc. |
PEGCETACOPLAN |
15 mg/.1mL |
1 VIAL, GLASS in 1 CARTON (73606-020-02) / 3 mL in 1 VIAL, GLASS |
| 73606-020-11 |
73606-020 |
HUMAN PRESCRIPTION DRUG |
Syfovre |
Pegcetacoplan |
INJECTION, SOLUTION |
INTRAVITREAL |
20230217 |
N/A |
NDA |
NDA217171 |
Apellis Pharmaceuticals, Inc. |
PEGCETACOPLAN |
15 mg/.1mL |
1 VIAL, GLASS in 1 CARTON (73606-020-11) / 3 mL in 1 VIAL, GLASS |
| 73606-020-12 |
73606-020 |
HUMAN PRESCRIPTION DRUG |
Syfovre |
Pegcetacoplan |
INJECTION, SOLUTION |
INTRAVITREAL |
20251107 |
N/A |
NDA |
NDA217171 |
Apellis Pharmaceuticals, Inc. |
PEGCETACOPLAN |
15 mg/.1mL |
1 VIAL, GLASS in 1 CARTON (73606-020-12) / 3 mL in 1 VIAL, GLASS |